DE102008008540A1 - Hautpflegezubereitung zur Pflege von gestresster Haut - Google Patents

Hautpflegezubereitung zur Pflege von gestresster Haut Download PDF

Info

Publication number: DE102008008540A1
Authority: DE; Germany
Prior art keywords: ellagic acid; skin care; care preparation; skin; preparation
Prior art date: 2008-02-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

DE102008008540A

Other languages

German (de)

English (en)

Inventor

Volker Dr. Achterberg

Andrea Heuer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Beiersdorf AG

Original Assignee

Beiersdorf AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-07

Filing date

2008-02-07

Publication date

2009-08-13

2008-02-07 Application filed by Beiersdorf AG filed Critical Beiersdorf AG

2008-02-07 Priority to DE102008008540A priority Critical patent/DE102008008540A1/de

2009-02-03 Priority to PCT/EP2009/000681 priority patent/WO2009098019A2/fr

2009-02-03 Priority to EP09708395A priority patent/EP2249766A2/fr

2009-08-13 Publication of DE102008008540A1 publication Critical patent/DE102008008540A1/de

Status Ceased legal-status Critical Current

Links

238000002360 preparation method Methods 0.000 title claims abstract description 55
AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 71
229920002079 Ellagic acid Polymers 0.000 claims description 70
ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 70
229960002852 ellagic acid Drugs 0.000 claims description 70
235000004132 ellagic acid Nutrition 0.000 claims description 70
FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 70
239000000725 suspension Substances 0.000 claims description 17
235000014360 Punica granatum Nutrition 0.000 claims description 12
239000000126 substance Substances 0.000 claims description 8
238000002604 ultrasonography Methods 0.000 claims description 5
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 4
238000000034 method Methods 0.000 claims description 4
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
235000013399 edible fruits Nutrition 0.000 claims description 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
240000009088 Fragaria x ananassa Species 0.000 claims description 2
241000758791 Juglandaceae Species 0.000 claims description 2
239000004909 Moisturizer Substances 0.000 claims description 2
244000172730 Rubus fruticosus Species 0.000 claims description 2
244000235659 Rubus idaeus Species 0.000 claims description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 2
229930003268 Vitamin C Natural products 0.000 claims description 2
229930003427 Vitamin E Natural products 0.000 claims description 2
235000021029 blackberry Nutrition 0.000 claims description 2
239000004202 carbamide Substances 0.000 claims description 2
239000006071 cream Substances 0.000 claims description 2
229960003624 creatine Drugs 0.000 claims description 2
239000006046 creatine Substances 0.000 claims description 2
150000002009 diols Chemical class 0.000 claims description 2
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
229920002674 hyaluronan Polymers 0.000 claims description 2
229960003160 hyaluronic acid Drugs 0.000 claims description 2
230000001333 moisturizer Effects 0.000 claims description 2
235000014571 nuts Nutrition 0.000 claims description 2
229940101267 panthenol Drugs 0.000 claims description 2
235000020957 pantothenol Nutrition 0.000 claims description 2
239000011619 pantothenol Substances 0.000 claims description 2
229920005862 polyol Polymers 0.000 claims description 2
150000003077 polyols Chemical class 0.000 claims description 2
230000008569 process Effects 0.000 claims description 2
235000021013 raspberries Nutrition 0.000 claims description 2
235000021012 strawberries Nutrition 0.000 claims description 2
235000013311 vegetables Nutrition 0.000 claims description 2
235000019154 vitamin C Nutrition 0.000 claims description 2
239000011718 vitamin C Substances 0.000 claims description 2
235000019165 vitamin E Nutrition 0.000 claims description 2
229940046009 vitamin E Drugs 0.000 claims description 2
239000011709 vitamin E Substances 0.000 claims description 2
235000020234 walnut Nutrition 0.000 claims description 2
239000011701 zinc Substances 0.000 claims description 2
229910052725 zinc Inorganic materials 0.000 claims description 2
235000016804 zinc Nutrition 0.000 claims description 2
239000000419 plant extract Substances 0.000 claims 4
244000294611 Punica granatum Species 0.000 claims 2
230000003115 biocidal effect Effects 0.000 claims 2
HVGWFBLSVZHTTQ-JYPJBZIJSA-N (5r,6s,7r,8r)-1,2,5,6,7,8,9-heptahydroxynonan-4-one Chemical compound OCC(O)CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO HVGWFBLSVZHTTQ-JYPJBZIJSA-N 0.000 claims 1
239000002253 acid Substances 0.000 claims 1
239000003139 biocide Substances 0.000 claims 1
239000007787 solid Substances 0.000 claims 1
239000008280 blood Substances 0.000 description 23
210000004369 blood Anatomy 0.000 description 23
230000035602 clotting Effects 0.000 description 17
206010053567 Coagulopathies Diseases 0.000 description 12
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 11
239000002953 phosphate buffered saline Substances 0.000 description 11
239000011550 stock solution Substances 0.000 description 11
241000219991 Lythraceae Species 0.000 description 10
238000012360 testing method Methods 0.000 description 10
241000196324 Embryophyta Species 0.000 description 5
208000027418 Wounds and injury Diseases 0.000 description 5
230000000694 effects Effects 0.000 description 5
230000023597 hemostasis Effects 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
102000009123 Fibrin Human genes 0.000 description 4
108010073385 Fibrin Proteins 0.000 description 4
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
206010052428 Wound Diseases 0.000 description 4
238000003556 assay Methods 0.000 description 4
230000023555 blood coagulation Effects 0.000 description 4
239000002537 cosmetic Substances 0.000 description 4
239000000284 extract Substances 0.000 description 4
229950003499 fibrin Drugs 0.000 description 4
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
239000004743 Polypropylene Substances 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
210000000416 exudates and transudate Anatomy 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
230000003902 lesion Effects 0.000 description 3
239000002245 particle Substances 0.000 description 3
229940109529 pomegranate extract Drugs 0.000 description 3
230000009467 reduction Effects 0.000 description 3
238000004904 shortening Methods 0.000 description 3
238000009210 therapy by ultrasound Methods 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
241001134446 Niveas Species 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
229940037003 alum Drugs 0.000 description 2
230000000740 bleeding effect Effects 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
238000000605 extraction Methods 0.000 description 2
LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
239000000499 gel Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
230000037311 normal skin Effects 0.000 description 2
239000003921 oil Substances 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
-1 polypropylene Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
230000029058 respiratory gaseous exchange Effects 0.000 description 2
239000007921 spray Substances 0.000 description 2
BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
JMGCAHRKIVCLFW-UHFFFAOYSA-N 1-O-Galloylcastalagin Natural products Oc1cc(cc(O)c1O)C(=O)OC2C3OC(=O)c4c2c(O)c(O)c(O)c4c5c(O)c(O)c(O)c6c5C(=O)OC3C7OC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OCC7OC(=O)c%10cc(O)c(O)c(O)c6%10 JMGCAHRKIVCLFW-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
244000062730 Melissa officinalis Species 0.000 description 1
235000010654 Melissa officinalis Nutrition 0.000 description 1
241000220317 Rosa Species 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
102000003425 Tyrosinase Human genes 0.000 description 1
108060008724 Tyrosinase Proteins 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940030225 antihemorrhagics Drugs 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
229920001968 ellagitannin Polymers 0.000 description 1
JMGCAHRKIVCLFW-CNWXVVPTSA-N ellagitannin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2C3=C4C(=O)O[C@@H]2[C@@H]2[C@@H]5OC(=O)C6=CC(O)=C(O)C(O)=C6C6=C(O)C(O)=C(O)C=C6C(=O)OC[C@H]5OC(=O)C5=CC(O)=C(O)C(O)=C5C=5C(O)=C(O)C(O)=C(C=5C(=O)O2)C4=C(O)C(O)=C3O)=C1 JMGCAHRKIVCLFW-CNWXVVPTSA-N 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000000417 fungicide Substances 0.000 description 1
235000004515 gallic acid Nutrition 0.000 description 1
229940074391 gallic acid Drugs 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000000025 haemostatic effect Effects 0.000 description 1
230000002439 hemostatic effect Effects 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000006623 intrinsic pathway Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
239000000865 liniment Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000003641 microbiacidal effect Effects 0.000 description 1
229940124561 microbicide Drugs 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000004091 panning Methods 0.000 description 1
239000000049 pigment Substances 0.000 description 1
239000011505 plaster Substances 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
150000008442 polyphenolic compounds Chemical class 0.000 description 1
235000013824 polyphenols Nutrition 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
230000000475 sunscreen effect Effects 0.000 description 1
239000000516 sunscreening agent Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000013169 thromboelastometry Methods 0.000 description 1
239000012873 virucide Substances 0.000 description 1
239000001993 wax Substances 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1
230000002087 whitening effect Effects 0.000 description 1
230000029663 wound healing Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/044—Suspensions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/002—Aftershave preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Birds (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Botany (AREA)
Microbiology (AREA)
Mycology (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)

DE102008008540A 2008-02-07 2008-02-07 Hautpflegezubereitung zur Pflege von gestresster Haut Ceased DE102008008540A1 (de)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
DE102008008540A DE102008008540A1 (de)	2008-02-07	2008-02-07	Hautpflegezubereitung zur Pflege von gestresster Haut
PCT/EP2009/000681 WO2009098019A2 (fr)	2008-02-07	2009-02-03	Préparations de soins pour peau stressée
EP09708395A EP2249766A2 (fr)	2008-02-07	2009-02-03	Préparations de soins pour peau stressée

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102008008540A DE102008008540A1 (de)	2008-02-07	2008-02-07	Hautpflegezubereitung zur Pflege von gestresster Haut

Publications (1)

Publication Number	Publication Date
DE102008008540A1 true DE102008008540A1 (de)	2009-08-13

Family

ID=40847371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE102008008540A Ceased DE102008008540A1 (de)	2008-02-07	2008-02-07	Hautpflegezubereitung zur Pflege von gestresster Haut

Country Status (3)

Country	Link
EP (1)	EP2249766A2 (fr)
DE (1)	DE102008008540A1 (fr)
WO (1)	WO2009098019A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110327227A (zh) *	2019-08-01	2019-10-15	上海应用技术大学	一种含有鞣花酸的水凝胶微球及其制备方法
CN114028332A (zh) *	2021-12-02	2022-02-11	南京中医药大学	一种鞣花酸纳米混悬液及其在口服、外用制剂和化妆品中的应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5055412A (en) *	1989-03-21	1991-10-08	Proksch Gary J	Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
JP2000247866A (ja) *	1998-12-28	2000-09-12	Lion Corp	皮膚外用剤
US20020082220A1 (en) *	2000-06-29	2002-06-27	Hoemann Caroline D.	Composition and method for the repair and regeneration of cartilage and other tissues
JP2003160461A (ja) *	2001-11-21	2003-06-03	Shiseido Co Ltd	皮膚外用剤
EP1790238A1 (fr) *	2004-08-02	2007-05-30	Kaneka Corporation	Composition blanchissante à contenu réduit d"ubiquinone
US20070237834A1 (en) *	2003-04-18	2007-10-11	Bioderm Research	Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6479103A (en) *	1987-06-09	1989-03-24	Lion Corp	External preparation
AU663683B2 (en) *	1990-04-17	1995-10-19	Analytical Control Systems, Inc.	Coagulation assays and reagents
FR2671723B1 (fr) *	1991-01-22	1995-01-13	Synthelabo	Extraits de noix d'alep, leur preparation et leurs applications.
US6066312A (en) *	1996-07-16	2000-05-23	Lion Corporation	Topical composition for application to the skin containing an ellagic acid-based compound or salt thereof
FR2768927B1 (fr) *	1997-10-01	2000-01-21	Lvmh Rech	Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
WO2007004229A2 (fr) *	2005-07-06	2007-01-11	Rimonest Ltd.	Methodes d'utilisation de fractions de grenades pour reparer la peau
FR2893505B1 (fr) *	2005-11-23	2007-12-28	Oreal	Dispersion aqueuse d'acide ellagique et son utilisation en cosmetique
JP2008075221A (ja) *	2006-09-22	2008-04-03	Nicca Chemical Co Ltd	洗濯用皮膚保護性仕上げ剤、及びそれを用いた皮膚保護性付与方法

2008
- 2008-02-07 DE DE102008008540A patent/DE102008008540A1/de not_active Ceased
2009
- 2009-02-03 WO PCT/EP2009/000681 patent/WO2009098019A2/fr not_active Ceased
- 2009-02-03 EP EP09708395A patent/EP2249766A2/fr not_active Ceased

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5055412A (en) *	1989-03-21	1991-10-08	Proksch Gary J	Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
JP2000247866A (ja) *	1998-12-28	2000-09-12	Lion Corp	皮膚外用剤
US20020082220A1 (en) *	2000-06-29	2002-06-27	Hoemann Caroline D.	Composition and method for the repair and regeneration of cartilage and other tissues
JP2003160461A (ja) *	2001-11-21	2003-06-03	Shiseido Co Ltd	皮膚外用剤
US20070237834A1 (en) *	2003-04-18	2007-10-11	Bioderm Research	Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
EP1790238A1 (fr) *	2004-08-02	2007-05-30	Kaneka Corporation	Composition blanchissante à contenu réduit d"ubiquinone

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
A. Girolami et al., Blood 27 (1966), 93-102
ISO 10993-4, Teil B3
J. A. Caprini et al., 'Perspectives an thromboelastography', Semin. Thromb. Hemost. 21 (Suppl. 4, 1995), 91-93
M. N. Aslam et al. (J. Ethnopharmacol. 103 (2006), 311-318)
T. Exner & K. A. Rickard, Thromb. Res. 26 (1982), 83-89
Takada & Tanaka, in Eisner & Maibach (Eds.), Cosmetic Science and Technology Vol. 27, (2005), Ch. 28, p.511-521

Also Published As

Publication number	Publication date
EP2249766A2 (fr)	2010-11-17
WO2009098019A2 (fr)	2009-08-13
WO2009098019A3 (fr)	2009-11-05
WO2009098019A4 (fr)	2009-12-23

Publication	Publication Date	Title
DE69426064T2 (de)	2001-05-10	Kosmetische Zusammensetzung enthaltend einen pflanzlichen extrazellularen Matrixextrakt
DE10084749B4 (de)	2013-02-07	Substrat, welches mit einer Zusammensetzung behandelt ist, die einen botanischen Extrakt und ein Tensid enthält, sowie Körperpflegeartikel, welcher das behandelte Substrat enthält
DE1617317B2 (de)	1978-04-20	Knorpelmasse
EP2869854A1 (fr)	2015-05-13	Composition contenant, en tant que principe actif, de l'ectoïne ou de l'hydroxyectoïne pour la reconstruction de tissus corporels lésés
EP1140006A1 (fr)	2001-10-10	Agents pour proteger la peau, contenant un melange de fragments produit par hydrolyse a partir d'acide hyaluronique
DE69121405T2 (de)	1997-01-23	Verfahren zur verminderung der reizenden eigenschaften von kosmetischen zusammensetzungen
EP3494850A1 (fr)	2019-06-12	Lingette humide avec hydroxyacetophenon
DE102008008540A1 (de)	2009-08-13	Hautpflegezubereitung zur Pflege von gestresster Haut
JP4658631B2 (ja)	2011-03-23	入浴剤組成物
DE2321306A1 (de)	1974-11-14	Hautpflegemittel
CN107440920A (zh)	2017-12-08	一种深层螯合美容洁面面膜及制备方法
RU2671511C1 (ru)	2018-11-01	Косметическая композиция для ухода за волосами и кожей головы (варианты)
KR20170099096A (ko)	2017-08-31	피부 주름 개선용 화장료 조성물
DE10297369T5 (de)	2004-10-28	Anwendung von Oligosacchariden in kosmetischen oder dermatologischen Zusammensetzungen zum Stimulieren der Haftung von Keratinozyten an den Hauptproteinen der Lederhaut-Epidermis-Verbindung und zum Wiederherstellen der Epidermiskohäsion
DE102008008537A1 (de)	2009-08-13	Wundversorgungsartikel
DE3330628A1 (de)	1985-03-07	Hautschutz- und -pflegelotion
DE1492023C3 (de)	1974-07-18	Hautpflegemittel
EP2825265B1 (fr)	2017-11-01	Produit cosmétique pour peau mâture
CN115337243A (zh)	2022-11-15	祛黑头组合物和化妆品
JP6118581B2 (ja)	2017-04-19	神経成長因子産生抑制剤およびそれを用いた化粧品、皮膚外用剤
EP4051217B1 (fr)	2024-01-10	Composition cosmétique contenant un extrait d'opuntia ficus indica
CN120514648B (zh)	2025-11-04	具有皮肤养护作用的植物提取物组合物及其应用
JP2537444B2 (ja)	1996-09-25	紫外線防御および防皺剤
DE2653595C2 (de)	1985-08-01	Verfahren zum Extrahieren von embryonaler Kälberhaut, der dabei erhaltene Extrakt sowie dessen Verwendung als Wirkstoff in Mitteln zur Behandlung der Haut
KR102689356B1 (ko)	2024-08-05	천연소재를 이용해 자외선 차단, 미백 및 항균 기능을 제공하는 화장료 조성물

Legal Events

Date	Code	Title	Description
2009-08-13	OM8	Search report available as to paragraph 43 lit. 1 sentence 1 patent law
2014-08-07	R012	Request for examination validly filed	Effective date: 20140619
2016-04-04	R002	Refusal decision in examination/registration proceedings
2016-05-10	R003	Refusal decision now final